XML 51 R41.htm IDEA: XBRL DOCUMENT v3.25.2
BASIS OF PRESENTATION - Schedule of Revision of Previously Issued Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Total revenue $ 85,729 $ 85,600 $ 172,937 $ 169,717
Operating income (loss) 3,627 (2,149) 11,787 (2,737)
Income (loss) before taxes 698 (6,300) 5,620 (9,538)
Provision for (benefit from) income taxes (1,882) (1,912) 2,581 (3,296)
Net income (loss) $ 2,580 $ (4,388) $ 3,039 $ (6,242)
Net income (loss) per share - basic (in dollars per share) $ 0.17 $ (0.29) $ 0.20 $ (0.42)
Net income (loss) per share - diluted (in dollars per share) $ 0.17 $ (0.29) $ 0.20 $ (0.42)
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss) $ 2,568 $ (4,393) $ 3,021 $ (6,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   3,633 (14,952) 5,487
Beginning balance 168,508 182,690 168,695 183,973
Accumulated earnings (deficit) ending balance (11,913) (755) (11,913) (755)
Ending balance 173,173 179,780 173,173 179,780
Condensed Consolidated Statement of Cash Flows        
Accounts receivable     (3,967) (1,085)
Income taxes, net     (3,487) (263)
Financial Health        
Revenue:        
Total revenue 54,284 54,509 110,417 107,948
Patient Care        
Revenue:        
Total revenue $ 31,445 31,091 $ 62,520 61,769
As previously reported        
Revenue:        
Total revenue   84,730   167,977
Operating income (loss)   (3,019)   (4,477)
Income (loss) before taxes   (7,170)   (11,278)
Provision for (benefit from) income taxes   (2,121)   (3,713)
Net income (loss)   $ (5,049)   $ (7,565)
Net income (loss) per share - basic (in dollars per share)   $ (0.34)   $ (0.51)
Net income (loss) per share - diluted (in dollars per share)   $ (0.34)   $ (0.51)
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss)   $ (5,054)   $ (7,457)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   5,616   8,132
Beginning balance   184,673   186,618
Accumulated earnings (deficit) ending balance   567   567
Ending balance   181,102   181,102
Condensed Consolidated Statement of Cash Flows        
Accounts receivable       654
Income taxes, net       (679)
As previously reported | Financial Health        
Revenue:        
Total revenue   54,108   107,146
As previously reported | Patient Care        
Revenue:        
Total revenue   30,622   60,831
Impact of revision        
Revenue:        
Total revenue   870   1,740
Operating income (loss)   870   1,740
Income (loss) before taxes   870   1,740
Provision for (benefit from) income taxes   209   417
Net income (loss)   $ 661   $ 1,323
Net income (loss) per share - basic (in dollars per share)   $ 0.05   $ 0.09
Net income (loss) per share - diluted (in dollars per share)   $ 0.05   $ 0.09
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss)   $ 661   $ 1,323
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   (1,983)   (2,645)
Beginning balance   (1,983)   (2,645)
Accumulated earnings (deficit) ending balance   (1,322)   (1,322)
Ending balance   (1,322)   (1,322)
Condensed Consolidated Statement of Cash Flows        
Accounts receivable       (1,739)
Income taxes, net       416
Impact of revision | Financial Health        
Revenue:        
Total revenue   401   802
Impact of revision | Patient Care        
Revenue:        
Total revenue   $ 469   $ 938